Tag: Capricor Therapeutics
Deramiocel Scores FDA Orphan Drug Designation, Boosting Capricor Therapeutics ($CAPR) Pipeline
Capricor Therapeutics (CAPR) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to Deramiocel. Deramiocel is the lead cell therapy...